Teva Pharmaceutical Industries LimitedTEVANYSE
LOADING
|||
Operating Income Contraction
Trending lower, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-303.00M
↑ 83% above average
Average (9y)
$-1.80B
Historical baseline
Range
High:$3.35B
Low:$-17.48B
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-303.00M | -170.0% |
| 2023 | $433.00M | +119.7% |
| 2022 | $-2.20B | -228.0% |
| 2021 | $1.72B | +148.0% |
| 2020 | $-3.57B | -706.3% |
| 2019 | $-443.00M | +72.9% |
| 2018 | $-1.64B | +90.6% |
| 2017 | $-17.48B | -911.7% |
| 2016 | $2.15B | -35.7% |
| 2015 | $3.35B | - |